Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases.
Oncotarget
; 7(31): 50461-50476, 2016 Aug 02.
Article
in En
| MEDLINE
| ID: mdl-27409163
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pyrans
/
Tamoxifen
/
Breast Neoplasms
/
Receptor Protein-Tyrosine Kinases
/
Lysosomes
Limits:
Female
/
Humans
Language:
En
Journal:
Oncotarget
Year:
2016
Document type:
Article
Affiliation country:
Germany
Country of publication:
United States